mobile background

mobile background


Pie healthcare : AI software

DOCTOR EYE | X-EYE

DOCTOREYE X-EYE is an AI software solution that analyzes optical fundus images to detect the presence of ophthalmic diseases including age-related Macular degeneration, Diabetic retinopathy, Glaucoma, and Epiretinal membrane within seconds.

By doing so, it supports clinical decision-making by healthcare professionals.

*Approval from the Ministry of Food and Drug Safety (No. D 26-1)

Characteristic : X-EYE

1. EYE diseases

  • Macular degeneration
  • Diabetic retinopathy
  • Glaucoma
  • Epiretinal membrane

2. heat map

Key regions analyzed by the AI can be visualized through heat maps.

3. Report

To enable users to intuitively review examination results, the system provides the analysis results for easy interpretation.

4. R&D

  • 2024: Development of DOCTOREYE X-EYE completed

  • 2025: Regulatory and commercialization processes for DOCTOREYE X-EYE are currently underway

  • Approval from the Ministry of Food and Drug Safety (No. D 26-1)


mobile background

Pie healthcare : AI software

DOCTOR EYE | X-EYE

DOCTOREYE X-EYE is an AI software solution that analyzes optical fundus images to detect the presence of ophthalmic diseases including age-related Macular degeneration, Diabetic retinopathy, Glaucoma, and Epiretinal membrane within seconds.

By doing so, it supports clinical decision-making by healthcare professionals.


*Approval from the Ministry of Food and Drug Safety (No. D 26-1)


Characteristic : X-EYE

1. EYE dieases

  • Macular degeneration
  • Diabetic retinopathy
  • Glaucoma
  • Epiretinal membrane
Macular degeneration
Macular degeneration
Diabetic retinopathy
Diabetic retinopathy
Glaucoma
Glaucoma
Epiretinal membrane
Epiretinal membrane

2. heat map

The system highlights key regions analyzed by the AI through heat map visualizations, enhancing interpretability for clinicians.


Macular degeneration
Macular degeneration
Macular degeneration
Macular degeneration
Glaucoma
Glaucoma
Glaucoma
Glaucoma

3. Report

To enable users to intuitively review examination results, the system provides the analysis results for easy interpretation.

4. Research and Development

  • 2024: Development of DOCTOREYE X-EYE completed

  • 2025: Regulatory and commercialization processes for DOCTOREYE X-EYE are currently underway

  • Approval from the Ministry of Food and Drug Safety (No. D 26-1)